Xyrem (sodium oxybate) oral solution.
Ended Awarded Last action
- Contract number
- 36C26025F0044
- Awardee
-
Amneal Pharmaceuticals Of New York, LLC UEI LVEBAQTPN615
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $173,089
Award facts
- Contract value 100% obligated
- $173,088.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Normandy, MO 63121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$482 | |
| Original award | $173,571 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $173,088.68 delivery order contract to Amneal Pharmaceuticals of New York, LLC for the supply of Xyrem (sodium oxybate) oral solution. The contract, issued on November 1, 2024, under the GSA Multiple Award Schedule for Pharmaceuticals and Drugs (FSS-61-IB), carries a firm fixed price and requires completion by October 31, 2025, with performance taking place in Normandy, Missouri. This delivery order was issued without a set-aside designation, reflecting open competition on the federal marketplace for this specialized pharmaceutical product.
This award represents part of Amneal's established role as a pharmaceutical supplier to the Veterans Affairs system, with the company having received multiple delivery orders from VISN 20 totaling approximately $670,443 in ceiling values since November 2023. Amneal's pharmaceutical portfolio also includes a $2.5 million Blanket Purchase Agreement with the National Acquisition Center for sodium oxybate and additional contracts with the VA and Department of Defense focused on specialized medications and medical countermeasures. Xyrem is primarily used to treat narcolepsy and represents a critical medication within the VA's veteran healthcare programs.
Quick answers
Who was awarded contract 36C26025F0044?
36C26025F0044 was awarded to Amneal Pharmaceuticals Of New York, LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 1, 2024.
How much is contract 36C26025F0044 worth?
The government has obligated $173,089 on 36C26025F0044.
Is contract 36C26025F0044 an order under another contract?
Yes. 36C26025F0044 is a delivery order under 36F79722D0161, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0044 competed?
The extent of competition for 36C26025F0044 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award